SCHEMBL6282919

SCHEMBL6282919

CS(=O)(=O)c1nc(C(=O)NNc2nncc3ccccc23)sc1CCO[N+](=O)[O-]

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2D6 P10635 2/20 0.45
HIF1A Q16665 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
EGFR P00533 11/20 0.39
KDR P35968 11/20 0.39
ALDH1A1 P00352 3/20 0.39
GAA P10253 1/20 0.39
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CYP2C9 P11712 1/20 0.32
ALOX15 P16050 1/20 0.32
CYP2C19 P33261 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MPO P05164 2/20 0.31
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
KDM4E B2RXH2 1/20 0.31
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL259114 0.89 LMNA (0.49) LMNACYP1A2CYP2D6HIF1ATDP1
SCHEMBL279627 0.74 LMNA (0.51) LMNACYP1A2CYP2D6HIF1ATDP1
SCHEMBL12765309 0.71 LMNA (0.61) LMNACYP1A2CYP2D6HIF1ATDP1
SCHEMBL5232780 0.71 LMNA (0.34) LMNACYP1A2CYP2D6HIF1ATDP1
SCHEMBL31506911 0.64 LMNA (0.67) LMNACYP1A2CYP2D6HIF1ATDP1
Todralazine SCHEMBL29673003 0.63 LMNA (1.00) LMNACYP1A2CYP2D6HIF1ATDP1
Todralazine SCHEMBL49644 0.63 LMNA (1.00) LMNACYP1A2CYP2D6HIF1ATDP1
Todralazine SCHEMBL211261 0.62 TDP1 (1.00) LMNACYP1A2CYP2D6HIF1ATDP1
Nicorandil SCHEMBL7617249 0.62 KMT2A (0.69) LMNACYP1A2CYP2D6TDP1ALDH1A1
Todralazine SCHEMBL1417412 0.62 TDP1 (0.97) LMNACYP1A2CYP2D6HIF1ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005105065-A2 THIAZOLE-BASED NITRIC OXIDE DONORS FOR TREATING INFLAMMATORY BOWEL DISEASES RENOPHARM LTD. (IL) 2005-11-10 WO disclosed